Global X Funds's Global X Genomics & Biotechnology ETF (GNOM) has disclosed 40 total holdings in their latest N-PORT filing with the SEC for the
portfolio date of 2024-05-31. The current portfolio value is calculated to be $93.00 Mil, only including common equities, preferred
equities, ETFs, options and warrants for equities. The turnover rate is 15%.
Global X Genomics & Biotechnology ETF (GNOM)'s
Total Assets is $92.76 Mil , Total Liabilities is $40,610.00 , Net Assets is $92.72 Mil.
In Global X Genomics & Biotechnology ETF (GNOM)'s current portfolio as of 2024-05-31, the top 5 holdings are
Moderna Inc (MRNA), Bio-Techne Corp (TECH), Natera Inc (NTRA), BioNTech SE (BNTX) and Sarepta Therapeutics Inc (SRPT),
not including call and put options.
Global X Genomics & Biotechnology ETF (GNOM) did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the ETF's current and past N-PORT holdings for Global X Genomics & Biotechnology ETF (GNOM), as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at 52-week lows, etc.
Please visit the "Stock Picks" tab to see the ETF's latest trades and stock picks for Global X Genomics & Biotechnology ETF (GNOM), which include data from form N-PORT.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for Global X Genomics & Biotechnology ETF.